Oncology has come a long way in just a few decades to the point where cancer care is increasingly understood as a chronic condition, but more capacity is still needed. At HBI 2023, oncology panelists debated where the best opportunities for growth in the sector lie. Here were some of the takeaways:
Regulatory changes are one of the major concerns among players in healthcare services. A busy panel of lawyers, operators and investors considered this thorny issue at HBI 2023, with a general feeling that even the strictest of regulations can provide some kind of opportunity, and that private funding is so essential a component in health care today, it cannot be legislated away.
Last month, thought leaders from private healthcare systems across the globe gathered in Cape Town, South Africa, to network, share their findings, and consider how emerging markets can become more resilient. HBI was there, and these are our key themes and takeaways.
Global chemicals company Linde reported a 1% year-on-year drop in sales growth for healthcare, despite double-digit sales growth in all its other end markets.
The slump in healthcare listed stocks and downward valuations of private businesses are encouraging potential buyers to examine enticing European healthcare enterprises.
HBI catches up with co-founders Frederic Llordachs, CEO, and Carmen Pauline Rios Benton, COO, of new chronic disease monitoring group Doctomatic, a remote patient monitoring solution for chronic conditions like diabetes, hypertension, COPD and heart failure, which uses AI to help detect problems at an early stage.
Profound pessimism about NHS plans for integrated health and with NHS systems in the UK and Canada was on display from academics at the European Health Policymakers Group which celebrated its 21st year in an afternoon looking at what the group had learnt studying Beveridge (NHS) and Bismarckian (statutory insurer) models.
A Swedish pension fund is investing via a social bond in a programme that aims to stop unfit 50-60 year olds in Stockholm developing diabetes 2 and other expensive conditions. The scheme, run by a start up, is set to roll out more widely in Sweden and internationally. Bogi Eliasen, Director of Health at the Copenhagen Institute For Futures Studies says that Scandinavian countries, Qatar and Saudi Arabia are all keen to up prevention spend and are looking at similar schemes.
Fresenius Helios plans to become the first and only global health care service player by rolling out its Curalie telehealth plus a prefab diagnostic unit (the Cube) starting in Vietnam in October. Deals are being struck with governments in Ghana and Kenya for the group to offer primary care for €10 per cap. to millions. We talk to Fresenius Helios CEO Franceso de Meo.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
